Home / Specialties / Nephrology (page 6)

Nephrology

Nephrology and Kidney Care for Diabetics: Diabetes causes tremendous stress and damage to the kidneys. Diabetes patients are frequently renally impaired and at high risk for kidney failure if not on dialysis. This further complicates the management of their diabetes and increases mortality risk. However, new treatments, drugs, and clinical insights are aiding medical professionals in their fight against kidney disease and its relationship to diabetes.

Ethnicity Can Affect Risk for Diabetes Complications

Feb 13, 2021 Articles, Cardiology, Nephrology, Paid 3,082 views

A diabetes patient’s risk for chronic kidney disease or cardiovascular disease can be impacted by various factors, including ethnic background.

Analysis of Sotagliflozin’s Effect on Cardiorenal Factors for Type 1 Patients

Feb 2, 2021 Articles, Nephrology, SGLT-2 Therapy Center 2,881 views

Can use of the sodium-glucose cotransporter 1 and sodium-glucose cotransporter 2 dual inhibitor in patients with type 1 diabetes preserve kidney function?

Dipeptidyl Peptidase-4 Role in Patients with Renal Transplant

Jan 9, 2021 Articles, DPP-4 Therapy Center, Nephrology, Type 2 Diabetes 8,840 views

Diabetes management can be a major factor in renal transplant aftercare; can DPP-4 therapy help improve outcomes?

Empagliflozin Effect on Major Adverse Kidney Events

Dec 12, 2020 Nephrology, SGLT-2 Therapy Center 4,022 views

A cohort study on the risk of major adverse kidney events for new patients initiated on empagliflozin versus other non-SGLT2I antihyperglycemics.

The Effect of Dapagliflozin on Renal Disease Progression

Nov 28, 2020 Nephrology, Paid, SGLT-2 Therapy Center 4,393 views

There is a potential role in using dapagliflozin in patients with CKD.

Optimal Treatment In T2D For CV Protection

Nov 21, 2020 Cardiology, Nephrology, Type 2 Diabetes 4,077 views

How triple therapy can lead to optimal cardiovascular and renal protection.

The Benefits of Exenatide From the EXSCEL Study

Nov 14, 2020 GLP-1 Agonist Therapy Center, Nephrology 3,683 views

The EXSCEL trial may not have shown that once-weekly exenatide had cardiovascular benefits for patients with diabetes, but did show a benefit in some significant areas.